Amp 2024 Usfda. Health regulator has issued a warning to intas pharmaceuticals, citing manufacturing lapses, including breaches of current good manufacturing practice. The amp conference is where academic meets practice!

In october 2023, the center for devices and radiological health (cdrh). All doses of eli lilly &